@aieshamyricks's GLP-1 weight loss claims, fact-checked

What does this video actually claim?

@aieshamyricks says she lost 11 pounds using GLP-1 medication after exercise plateaus stopped working for her PCOS-related weight issues. She mentions switching between telehealth providers for "personalized care guided by a dr" and promotes signing up through her bio link.

The creator doesn't name the specific medication but uses #glp1 hashtags. She suggests the treatment worked where previous efforts like walking 1,000 steps daily for 90 days had hit a plateau. The video functions as both personal testimony and affiliate marketing for telehealth services.

Does the science back up GLP-1s for PCOS weight management?

Yes, but the evidence is stronger for some medications than others. The STEP 1 trial (Wilding et al., NEJM, 2021) showed 14.9% average weight loss with 2.4mg semaglutide over 68 weeks in adults with obesity.

For PCOS specifically, a 2022 systematic review (Elkind-Hirsch et al., Endocrine Practice) found that GLP-1 receptor agonists improved both metabolic and reproductive outcomes in women with PCOS. Liraglutide studies showed 5-7% weight loss over 26 weeks in PCOS patients.

However, 11 pounds represents roughly 5-7% body weight loss for most women, which sits at the lower end of typical GLP-1 results. The creator's timeframe isn't specified, making it hard to evaluate whether this represents expected progress.

What's missing from this testimonial?

The video lacks several important details that would help viewers understand the full picture. She doesn't specify which GLP-1 medication she's using (semaglutide, tirzepatide, or liraglutide all have different efficacy profiles).

More problematically, she doesn't mention common side effects. The STEP trials reported nausea in 44% of participants, vomiting in 24%, and diarrhea in 30%. These aren't minor details when you're promoting a treatment to 92,500 viewers.

The creator also doesn't address cost. GLP-1 medications typically run $800-1,200 monthly without insurance coverage. Many insurance plans don't cover these drugs for weight management, making long-term affordability a real concern for most people.

Are telehealth providers the right approach?

Telehealth can work for GLP-1 prescribing, but quality varies dramatically between platforms. Legitimate services require comprehensive medical history, lab work, and ongoing monitoring for side effects and drug interactions.

The creator mentions switching providers, which could be a red flag. Doctor shopping for easier prescriptions isn't appropriate medical care. Proper GLP-1 treatment involves careful dose titration starting at 0.25mg weekly for semaglutide, with increases every 4 weeks based on tolerance and response.

Some telehealth companies promote these medications too aggressively to people who don't meet clinical criteria. The FDA criteria require BMI of 30+ or BMI 27+ with weight-related health conditions. PCOS can qualify, but proper evaluation matters.

What should you actually know about GLP-1s?

These medications work by slowing gastric emptying and affecting appetite regulation in the brain. They're not magic bullets, and most people regain weight when stopping treatment.

The STEP 4 trial (Rubino et al., JAMA, 2021) showed that participants regained two-thirds of their lost weight within one year of discontinuing semaglutide. This means you're likely looking at long-term treatment with ongoing costs.

For PCOS specifically, GLP-1s can help with insulin resistance and weight management, but they won't address all PCOS symptoms. Many women still need additional treatments for irregular periods, acne, or excess hair growth. Setting realistic expectations matters more than following influencer testimonials.